Where does VisEn Medical, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), VisEn Medical, Inc. ranks #13,245 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does VisEn Medical, Inc. hold?

VisEn Medical, Inc. holds 23 US utility patents granted between 2015 and 2024, spanning 16 technology areas.

What is VisEn Medical, Inc.'s Innovation Score?

VisEn Medical, Inc. has an Innovation Score of 41.2 out of 100 (top 34% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does VisEn Medical, Inc. focus on?

VisEn Medical, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 18 patents, ranking #1,261 of 7,163 assignees active in that subclass. Grants appear in 16 CPC subclasses total.

Is VisEn Medical, Inc.'s patent grant rate increasing or decreasing?

VisEn Medical, Inc.'s recent grant velocity is -72% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for VisEn Medical, Inc.'s patents?

VisEn Medical, Inc.'s patents average 23.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the VisEn Medical, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

VisEn Medical, Inc.

USPTO PatentsView assignee record - 23 granted patents across 16 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Visen ranks #13,245 of 49,997 tracked US assignees by granted-patent volume, with 23 patents across 16 technology areas.

#13,245
of 49,997 US assignees by volume: Top 34%
by Innovation Score (41.2/100): 23.1
avg claims per patent: -72%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R13245 · US Corporation #13,245 · 23 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 23 grants
MID-PACK #13,245/49,997
PHOTO-FINISH Vector Vitale IP
CPC-FOCUS A61K · 16 areas
INNOV-PAR 41.2/100
CLAIMS-DENSE 23.1 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -72% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Vector Vitale IP LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Visen’s 41.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.0 pts (27%) Velocity 2.2 pts (5%) Breadth 14.1 pts (34%) Claim depth 13.9 pts (34%)

Qualcomm Incorporated · highest

85
VisEn Medical · this assignee

41
3D Lighting… · lowest

7

What this shows Visen's Innovation Score is 41.2/100 (top 34% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Visen?

Each dot is one of Visen’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Visen’s own 23.1 claims/patent is ABOVE the 13.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Visen vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Visen's grants concentrate

VisEn Medical, Inc. is a focused PatentsView assignee: 16 CPC subclasses with 78.3% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2018 (6 grants) versus a trough of 1 in 2015. By volume, Visen sits between Vector Vitale IP LLC and Webasto Charging Systems, Inc..

Visen's three-year grant acceleration

VisEn Medical, Inc. shows 2 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Vector Vitale IP

23
Versata Fz-

23
Vesuvius Group

23
Violin Systems

23
Vusiongroup

23
Washtech Holding

23
Wavetamer

23
Webasto Charging…

23
Visen Medical ◀

23

What this shows VisEn holds 23 patents at rank #13,240, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near VisEn

By rank, the assignees closest to #13,240 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in VisEn's primary technology class.

Visen's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 34% higher than 66% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

VisEn Medical, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	4.3%
2016	5	21.7%
2017	3	13.0%
2018	6	26.1%
2019	3	13.0%
2020	1	4.3%
2021	2	8.7%
2024	2	8.7%

Which technologies does VisEn Medical, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 18

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 17

C09B - Organic Dyes OR Closely-related Compounds FOR Producing Dyes ; , e.g. PIGMENTS; MORDANTS; Lakes 13

C07D - Heterocyclic Compounds 9

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 9

A61B - DIAGNOSIS; SURGERY; Identification 7

C07K - Peptides 3

Y02A - Technologies FOR Adaptation TO Climate Change 3

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 3

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 2

G01T - Measurement OF Nuclear OR X-radiation 1

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

C07C - Acyclic OR Carbocyclic Compounds 1

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 1

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 1

Top 15 of 16 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

VisEn Medical, Inc.'s patent record in context - here's where to go next.

VisEn Medical, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 78.3% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #13,245 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare VisEn Medical, Inc. against Vector Vitale IP LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.